US demand for implantable medical devices is forecast to increase 7.7 percent annually to $52 billion in 2015. Orthopedic implants will remain the largest segment and be one of the fastest growing. Pacing devices will lead gains among cardiovascular implants. Other implants expected to do well include neurostimulators and drug implants.
This study analyzes the $36 billion US implantable medical device industry. It presents historical demand data for the years 2000, 2005 and 2010, and forecasts for 2015 and 2020 by implant procedure, material and type (e.g., joint, spinal, orthobiologics, trauma, dental, pacing devices, stents, valves, ophthalmic, gynecological, drug, cosmetic).
The study also considers market environment factors, details industry structure, evaluates company market share and profiles 24 industry players, including Medtronic, Johnson & Johnson and Boston Scientific.